Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Dr Victoria Johnston

Clinical Associate Professor

United Kingdom

Jump to: Affiliations Publications

Affiliations
Department of Clinical Research
Faculty of Infectious and Tropical Diseases

Centres

TB Centre

Selected Publications
Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial.
Post, FA; Szubert, AJ; Prendergast, AJ; JOHNSTON, V; Lyall, H; Fitzgerald, F; Musiime, V; Musoro, G; Chepkorir, P; Agutu, C; Mallewa, J; Rajapakse, C; Wilkes, H; Hakim, J; Mugyenyi, P; Walker, AS; Gibb, DM; Pett, SL; Reduction of EArly mortaLITY in HIV-infected adult,;
2018
Clinical infectious diseases
Fever in the returning traveller.
Fink, D; Wani, RS; JOHNSTON, V;
2018
BMJ (Clinical research ed)
Effectiveness of Protease Inhibitor/Nucleos(t)ide Reverse Transcriptase Inhibitor-Based Second-line Antiretroviral Therapy for the Treatment of Human Immunodeficiency Virus Type 1 Infection in Sub-Saharan Africa: A Systematic Review and Meta-analysis.
Stockdale, AJ; SAUNDERS, MJ; Boyd, MA; Bonnett, LJ; JOHNSTON, V; Wandeler, G; Schoffelen, AF; Ciaffi, L; Stafford, K; Collier, AC; Paton, NI; Geretti, AM;
2017
Clinical infectious diseases
Resistance to tenofovir-based regimens during treatment failure of subtype C HIV-1 in South Africa.
Hoffmann, CJ; Ledwaba, J; Li, J-F; JOHNSTON, V; Hunt, G; FIELDING, KL; Chaisson, RE; CHURCHYARD, GJ; GRANT, AD; Johnson, JA; Charalambous, S; Morris, L;
2013
Antiviral therapy
Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug concentrations prior to switch.
JOHNSTON, V; Cohen, K; Wiesner, L; Morris, L; Ledwaba, J; FIELDING, KL; Charalambous, S; Churchyard, G; Phillips, A; GRANT, AD;
2013
The Journal of infectious diseases
Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review.
KRANZER, K; GOVINDASAMY, D; Ford, N; JOHNSTON, V; LAWN, SD;
2012
Journal of the International AIDS Society
Outcomes following virological failure and predictors of switching to second-line antiretroviral therapy in a South African treatment program.
JOHNSTON, V; FIELDING, KL; Charalambous, S; CHURCHYARD, G; Phillips, A; GRANT, AD;
2012
Journal of acquired immune deficiency syndromes (1999)
Second-line antiretroviral therapy in a workplace and community-based treatment programme in South Africa: determinants of virological outcome.
JOHNSTON, V; FIELDING, K; Charalambous, S; Mampho, M; Churchyard, G; Phillips, A; GRANT, AD;
2012
PloS one
Fever in returned travellers presenting in the United Kingdom: recommendations for investigation and initial management.
JOHNSTON, V; Stockley, JM; Dockrell, D; Warrell, D; BAILEY, R; Pasvol, G; Klein, J; Ustianowski, A; Jones, M; Beeching, NJ; BROWN, M; Chapman, AL N; Sanderson, F; WHITTY, CJ M; British Infection Society and the Hospital for Tro,;
2009
The Journal of infection
Global epidemiology and control of Trichomonas vaginalis.
JOHNSTON, VJ; MABEY, DC;
2008
Current opinion in infectious diseases
See more information

Contact

United Kingdom